Literature DB >> 25132903

Case report: Intra-procedural aneurysm rupture during endovascular treatment causing immediate, transient angiographic vasospasm.

Zoe Zhang1, Farhan Siddiq1, Wondwossen G Tekle1, Ameer E Hassan1, Adnan I Qureshi1.   

Abstract

INTRODUCTION: Cerebral vasospasm is a major cause of delayed ischemic cerebral injury, typically occurring 3-14 days after subarachnoid hemorrhage (SAH). Ultra-early vasospasm is defined as angiographic vasospasm observed within 48 h of SAH onset. Immediate vasospasm at the time of aneurysmal rupture has been suspected, but has not been previously reported. We describe a case of immediate, transient vasospasm following intra-procedural aneurysmal rupture.
METHODS: A 55-year-old woman presented with SAH from a ruptured anterior communicating artery aneurysm. Subsequent coil embolization was complicated by an intra-procedural rupture following placement of the initial coil. A follow-up angiogram obtained after 9 min demonstrated moderate-to-severe vasospasm in the A2 segments of both anterior cerebral arteries.
RESULTS: A repeat angiogram 20 min later demonstrated complete resolution of the vasospasm. The aneurysm was successfully obliterated with coil embolization. Post-procedure, the patient manifested no clinical vasospasm and made a good neurological recovery.
CONCLUSION: We document a case of ultra-early cerebral vasospasm that occurred immediately after an intra-procedural aneurysmal rupture. Catheter-induced vasospasm from mechanical manipulation of extracranial vasculature is well described. However, immediate vasospasm related to extravascular blood has never before been reported. This finding suggests that extravascular blood can have a local direct effect (presumably mechanical) on cerebral blood vessels, and may be an important mechanism for vasospasm.

Entities:  

Keywords:  Vasospasm; aneurysm rupture; coil embolization; endovascular embolization

Year:  2014        PMID: 25132903      PMCID: PMC4132941     

Source DB:  PubMed          Journal:  J Vasc Interv Neurol        ISSN: 1941-5893


  18 in total

1.  Arteriographic demonstration of spasm of the intracranial arteries, with special reference to saccular arterial aneurysms.

Authors:  A ECKER; P A RIEMENSCHNEIDER
Journal:  J Neurosurg       Date:  1951-11       Impact factor: 5.115

Review 2.  Cerebral vasospasm following aneurysmal subarachnoid hemorrhage.

Authors:  N F Kassell; T Sasaki; A R Colohan; G Nazar
Journal:  Stroke       Date:  1985 Jul-Aug       Impact factor: 7.914

3.  Time course of vasospasm in man.

Authors:  B Weir; M Grace; J Hansen; C Rothberg
Journal:  J Neurosurg       Date:  1978-02       Impact factor: 5.115

4.  Clinical course of spontaneous subarachnoid hemorrhage: a population-based study in King County, Washington.

Authors:  W T Longstreth; L M Nelson; T D Koepsell; G van Belle
Journal:  Neurology       Date:  1993-04       Impact factor: 9.910

5.  Cerebral vasospasm after subarachnoid hemorrhage: an update.

Authors:  R C Heros; N T Zervas; V Varsos
Journal:  Ann Neurol       Date:  1983-12       Impact factor: 10.422

Review 6.  A review of hemoglobin and the pathogenesis of cerebral vasospasm.

Authors:  R L Macdonald; B K Weir
Journal:  Stroke       Date:  1991-08       Impact factor: 7.914

7.  Etiology of cerebral vasospasm in primates.

Authors:  R L Macdonald; B K Weir; T D Runzer; M G Grace; J M Findlay; K Saito; D A Cook; B W Mielke; K Kanamaru
Journal:  J Neurosurg       Date:  1991-09       Impact factor: 5.115

Review 8.  Endothelin and subarachnoid hemorrhage: an overview.

Authors:  M Zimmermann; V Seifert
Journal:  Neurosurgery       Date:  1998-10       Impact factor: 4.654

9.  Cerebral vasospasm with ruptured saccular aneurysm--the clinical manifestations.

Authors:  C M Fisher; G H Roberson; R G Ojemann
Journal:  Neurosurgery       Date:  1977 Nov-Dec       Impact factor: 4.654

Review 10.  The effect of surgery on the severity of vasospasm.

Authors:  R L Macdonald; M C Wallace; T J Coyne
Journal:  J Neurosurg       Date:  1994-03       Impact factor: 5.115

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.